• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名29岁男性,患致命性新型冠状病毒肺炎急性呼吸窘迫综合征(CARDS)及呼吸机相关性肺损伤(VILI)。

A 29-Year-Old Male with a Fatal Case of COVID-19 Acute Respiratory Distress Syndrome (CARDS) and Ventilator-Induced Lung Injury (VILI).

作者信息

Deliwala Smit S, Ponnapalli Anoosha, Seedahmed Elfateh, Berrou Mohammed, Bachuwa Ghassan, Chandran Arul

机构信息

Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA.

Department of Internal Medicine - Division of Pulmonology/Critical Care, Michigan State University at Hurley Medical Center, Flint, MI, USA.

出版信息

Am J Case Rep. 2020 Jul 23;21:e926136. doi: 10.12659/AJCR.926136.

DOI:10.12659/AJCR.926136
PMID:32701934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7405922/
Abstract

BACKGROUND COVID-19 patients that develop acute respiratory distress syndrome (ARDS) "CARDS" behave differently compared to patients with classic forms of ARDS. Recently 2 CARDS phenotypes have been described, Type L and Type H. Most patients stabilize at the milder form, Type L, while an unknown subset progress to Type H, resembling full-blown ARDS. If uncorrected, phenotypic conversion can induce a rapid downward spiral towards progressive lung injury, vasoplegia, and pulmonary shrinkage, risking ventilator-induced lung injury (VILI) known as the "VILI vortex". No cases of in-hospital phenotypic conversion have been reported, while ventilation strategies in these patients differ from the lung-protective approaches seen in classic ARDS. CASE REPORT A 29-year old male was admitted with COVID-19 pneumonia complicated by severe ARDS, multi-organ failure, cytokine release syndrome, and coagulopathy during his admission. He initially resembled CARDS Type L case, although refractory hypoxemia, fevers, and a high viral burden prompted conversion to Type H within 8 days. Despite ventilation strategies, neuromuscular blockade, inhalation therapy, and vitamin C, he remained asynchronous to the ventilator with volumes and pressures beyond accepted thresholds, eventually developing a fatal tension pneumothorax. CONCLUSIONS Patients that convert to Type H can quickly enter a spiral of hypoxemia, shunting, and dead-space ventilation towards full-blown ARDS. Understanding its nuances is vital to interrupting phenotypic conversion and entry into VILI vortex. Tension pneumothorax represents a poor outcome in patients with CARDS. Further research into monitoring lung dynamics, modifying ventilation strategies, and understanding response to various modes of ventilation in CARDS are required to mitigate these adverse outcomes.

摘要

背景

与患有经典形式急性呼吸窘迫综合征(ARDS)的患者相比,发展为急性呼吸窘迫综合征(“CARDS”)的新型冠状病毒肺炎(COVID-19)患者表现不同。最近描述了2种CARDS表型,即L型和H型。大多数患者病情稳定在较轻的L型,而有一部分未知患者会进展为H型,类似于典型的ARDS。如果不加以纠正,表型转换会导致病情迅速恶化,发展为进行性肺损伤、血管麻痹和肺萎陷,有发生呼吸机诱导性肺损伤(VILI)即“VILI漩涡”的风险。目前尚未报告院内表型转换的病例,而这些患者的通气策略与经典ARDS的肺保护性方法不同。病例报告:一名29岁男性因COVID-19肺炎入院,住院期间并发严重ARDS、多器官功能衰竭、细胞因子释放综合征和凝血病。他最初类似CARDS的L型病例,尽管难治性低氧血症、发热和高病毒载量促使其在8天内转换为H型。尽管采取了通气策略、神经肌肉阻滞、吸入治疗和维生素C治疗,他仍与呼吸机不同步,潮气量和压力超出可接受阈值,最终发展为致命的张力性气胸。结论:转换为H型的患者可迅速进入低氧血症、分流和无效腔通气的恶性循环,发展为典型的ARDS。了解其细微差别对于中断表型转换和进入VILI漩涡至关重要。张力性气胸是CARDS患者的不良结局。需要进一步研究监测CARDS患者的肺动力学、调整通气策略以及了解对各种通气模式的反应,以减轻这些不良后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2740/7405922/aef6246f8d3c/amjcaserep-21-e926136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2740/7405922/2cddf922c004/amjcaserep-21-e926136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2740/7405922/2b56aaff5978/amjcaserep-21-e926136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2740/7405922/aef6246f8d3c/amjcaserep-21-e926136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2740/7405922/2cddf922c004/amjcaserep-21-e926136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2740/7405922/2b56aaff5978/amjcaserep-21-e926136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2740/7405922/aef6246f8d3c/amjcaserep-21-e926136-g003.jpg

相似文献

1
A 29-Year-Old Male with a Fatal Case of COVID-19 Acute Respiratory Distress Syndrome (CARDS) and Ventilator-Induced Lung Injury (VILI).一名29岁男性,患致命性新型冠状病毒肺炎急性呼吸窘迫综合征(CARDS)及呼吸机相关性肺损伤(VILI)。
Am J Case Rep. 2020 Jul 23;21:e926136. doi: 10.12659/AJCR.926136.
2
Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report.机械通气的 COVID-19 患者在严重急性呼吸窘迫综合征康复过程中生理性死腔增加:病例报告。
BMC Infect Dis. 2020 Aug 27;20(1):637. doi: 10.1186/s12879-020-05360-5.
3
Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 相关急性呼吸窘迫综合征的流量控制通气:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 11;21(1):781. doi: 10.1186/s13063-020-04708-1.
4
Report of Two COVID-19 ARDS (CARDS) Cases Who Survived without Intubation and Mechanical Ventilation.两例未行气管插管和机械通气而存活的新型冠状病毒肺炎急性呼吸窘迫综合征(CARDS)病例报告。
Acta Med Indones. 2020 Jul;52(3):274-282.
5
A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.1例体外膜肺氧合作为COVID-19相关严重急性呼吸窘迫综合征挽救治疗的病例:越来越多的证据
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620957778. doi: 10.1177/2324709620957778.
6
Optimising Ventilator Use during the COVID-19 Pandemic.优化新冠疫情期间的呼吸机使用
J Coll Physicians Surg Pak. 2020 Jun;30(6):46-47. doi: 10.29271/jcpsp.2020.Supp1.S46.
7
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.地塞米松对中重度 COVID-19 相关急性呼吸窘迫综合征患者存活天数和无呼吸机天数的影响:CoDEX 随机临床试验。
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
8
Extracorporeal Membrane Oxygenation for Severe Respiratory Failure During Respiratory Epidemics and Pandemics: A Narrative Review.体外膜肺氧合在呼吸道传染病和大流行期间治疗严重呼吸衰竭:一项叙述性综述。
Ann Acad Med Singap. 2020 Apr;49(4):199-214.
9
Case Report of Patients with Acute Respiratory Distress Syndrome Caused by COVID-19: Successfully Treated by Venovenous Extracorporeal Membrane Oxygenation and an Ultra-Protective Ventilation.新型冠状病毒肺炎所致急性呼吸窘迫综合征患者的病例报告:应用静脉-静脉体外膜肺氧合和超保护性通气成功治疗。
Medicina (Kaunas). 2020 Oct 29;56(11):570. doi: 10.3390/medicina56110570.
10
Management of severe acute respiratory distress syndrome: a primer.严重急性呼吸窘迫综合征的管理:入门指南。
Crit Care. 2023 Jul 18;27(1):289. doi: 10.1186/s13054-023-04572-w.

引用本文的文献

1
Regulation of cell proliferation and transdifferentiation compensates for ventilator-induced lung injury mediated by NLRP3 inflammasome activation.细胞增殖和转分化的调节补偿了 NLRP3 炎性小体激活介导的呼吸机所致肺损伤。
Immun Inflamm Dis. 2023 Oct;11(10):e1062. doi: 10.1002/iid3.1062.
2
The Variable Nature of Vitamin C-Does It Help When Dealing with Coronavirus?维生素C的多变性质——应对冠状病毒时它有帮助吗?
Antioxidants (Basel). 2022 Jun 24;11(7):1247. doi: 10.3390/antiox11071247.
3
[Development of a giant bulla under spontaneous breathing by self-inflicted lung injury in a patient with COVID-19 pneumonia].

本文引用的文献

1
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.新型冠状病毒肺炎患者的尸检结果与静脉血栓栓塞
Ann Intern Med. 2020 Dec 15;173(12):1030. doi: 10.7326/L20-1206.
2
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
3
COVID-19: Timing is Important.新型冠状病毒肺炎:时机很重要。
[新型冠状病毒肺炎患者因自伤性肺损伤在自主呼吸下出现巨大肺大疱的病例]
Anaesthesist. 2022 Apr;71(4):303-306. doi: 10.1007/s00101-021-01072-w. Epub 2021 Nov 22.
4
Respiratory care for the critical patients with 2019 novel coronavirus.2019 新型冠状病毒危重症患者的呼吸支持治疗。
Respir Med. 2021 Sep;186:106516. doi: 10.1016/j.rmed.2021.106516. Epub 2021 Jun 21.
5
Vitamin C in the Treatment of COVID-19.维生素 C 治疗 COVID-19。
Nutrients. 2021 Apr 1;13(4):1172. doi: 10.3390/nu13041172.
6
Dexamethasone and transdehydroandrosterone significantly reduce pulmonary epithelial cell injuries associated with mechanical ventilation.地塞米松和去氢表雄酮可显著减轻机械通气相关的肺上皮细胞损伤。
J Appl Physiol (1985). 2021 Apr 1;130(4):1143-1151. doi: 10.1152/japplphysiol.00574.2020. Epub 2021 Feb 18.
7
A case of secondary tension pneumothorax in COVID-19 pneumonia in a patient with no prior history of lung disease.一名既往无肺部疾病史的新型冠状病毒肺炎患者发生继发性张力性气胸的病例。
SAGE Open Med Case Rep. 2020 Oct 17;8:2050313X20967504. doi: 10.1177/2050313X20967504. eCollection 2020.
8
The Inflammasome in Times of COVID-19.COVID-19 时期的炎症小体
Front Immunol. 2020 Oct 8;11:583373. doi: 10.3389/fimmu.2020.583373. eCollection 2020.
Eur J Intern Med. 2020 Jul;77:134-135. doi: 10.1016/j.ejim.2020.04.019. Epub 2020 Apr 13.
4
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality.新型冠状病毒病 2019(COVID-19)的呼吸状况:降低死亡率的新型治疗策略的重要考虑因素。
Med Hypotheses. 2020 Jul;140:109760. doi: 10.1016/j.mehy.2020.109760. Epub 2020 Apr 22.
5
Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers.SARS-CoV-2 的临床表型:对临床医生和研究人员的启示。
Eur Respir J. 2020 May 21;55(5). doi: 10.1183/13993003.01028-2020. Print 2020 May.
6
COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema.COVID-19 合并自发性气胸、纵隔气肿和皮下气肿。
J Travel Med. 2020 Aug 20;27(5). doi: 10.1093/jtm/taaa062.
7
Management of COVID-19 Respiratory Distress.新型冠状病毒肺炎呼吸窘迫的管理
JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.
8
Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings.新型冠状病毒肺炎患者的呼吸支持:关注资源有限的环境。
Am J Trop Med Hyg. 2020 Jun;102(6):1191-1197. doi: 10.4269/ajtmh.20-0283.
9
SARS-CoV-2 infection associated with spontaneous pneumothorax.与自发性气胸相关的新型冠状病毒2型感染
CMAJ. 2020 May 11;192(19):E510. doi: 10.1503/cmaj.200609. Epub 2020 Apr 21.
10
Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations.中国武汉 202 例 COVID-19 患者的紧急气管插管:经验教训和国际专家建议。
Br J Anaesth. 2020 Jul;125(1):e28-e37. doi: 10.1016/j.bja.2020.03.026. Epub 2020 Apr 10.